Glazer Capital »

Apogee Therapeutics shares owned by Glazer Capital

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Glazer Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $218M 1.6M 132.73

More positions owned by Glazer Capital

Topbuild Put Option
Penumbra Put Option (PEN)
Janus Henderson Group Ord Shs
Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Select Medical Holdings Corporation
Catalyst Pharmaceutical Partners (CPRX)
HudBay Minerals (HBM)
Digitalbridge Group Cl A New (DBRG)
Chart Industries (GTLS)
Caesars Entertainment (CZR)
Esperion Therapeutics (ESPR)
Webster Financial Corporation (WBS)
Sila Realty Trust Common Stock
Cyberark Software Note 0% 06/15/2030 (Principal)

View all positions for Glazer Capital

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
HBK Investments
Vanguard Capital Management
FMR
Henderson Group
Balyasny Asset Management
State Street Corporation
Driehaus Capital Management
Goldman Sachs Group
Glazer Capital
Paradigm Biocapital Advisors
Vanguard Portfolio Management
Millennium Management
Pentwater Capital Management

View all funds holding Apogee Therapeutics